The Cosentyx Drug Market is driven by steady funding from pharmaceutical companies
The global Cosentyx drug market is estimated to be valued at US$ 5.72 billion in 2025 and is expected to exhibit a CAGR of 7.5% over the forecast period 2025-2032.
Cosentyx is a biologic drug used for the treatment of plaque psoriasis and psoriatic arthritis. It works by blocking a specific part of the immune system called interleukin-17A (IL-17A). Cosentyx is administered through subcutaneous injection. The emergence of humanized monoclonal antibodies that selectively target specific cytokines like IL-17A has transformed the treatment of autoimmune conditions like psoriasis and arthritis. Cosentyx provides relief from symptoms with minimal side effects vis-à-vis other therapeutic options.
Cosentyx Drug Market- https://themediumblog.com/read-blog/160381
#coherentmarketinsights #cosentyxdrugmarket #cosentyxdrug #cosentyxdrugmarketdemand #autoimmunedisease